Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension

Clinical Transplantation
Felix Perez-VillaEulalia Roig

Abstract

Pre-operative elevated pulmonary vascular resistance (PVR) has been associated with increased right ventricular failure and mortality after heart transplantation. The aim of this study was to assess the efficacy of bosentan, an oral endothelin-receptor antagonist, to reduce PVR in patients considered ineligible for heart transplantation because of severe pulmonary hypertension. Seven patients with end-stage congestive heart failure and considered ineligible for heart transplantation because of severe pulmonary hypertension (PVR>2.5 Wood units after nitroprusside infusion) were included in the study. They received bosentan 62.5 mg b.i.d. for four wk and 125 mg b.i.d. thereafter. Right heart catheterization was repeated after six wk of therapy. After six wk of bosentan therapy, there was a significant decrease in PVR (6.0 +/- 2 vs. 3.8 +/- 2 Wood units, before vs. after bosentan; p = 0.02), in PVR during nitroprusside infusion (3.3 +/- 1 vs. 2.1 +/- 1 Wood units, before vs. after bosentan; p = 0.02) and in diastolic pulmonary artery pressure (33 +/- 7 vs. 23 +/- 7 mmHg, before vs. after bosentan; p = 0.04). No significant adverse events were observed. After bosentan therapy, five patients had PVR<or=2.5 Wood units. They were incl...Continue Reading

References

May 1, 1988·Journal of the American College of Cardiology·J K KirklinR B Karp
Aug 1, 1971·American Journal of Surgery·R B GrieppN E Shumway
Mar 1, 1995·Mayo Clinic Proceedings·R J Lunn
Jun 1, 1996·The Annals of Thoracic Surgery·D A Fullerton, R C McIntyre
Sep 2, 1998·Transplantation Proceedings·T AzizA Deiraniya
Oct 25, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·J D HosenpudR J Novick
Oct 5, 2001·Journal of the American College of Cardiology·B Stobierska-DzierzekR E Michler
Mar 22, 2002·The New England Journal of Medicine·Lewis J RubinGerald Simonneau
Nov 5, 2003·Circulation·Stuart Rich, Vallerie V McLaughlin
May 18, 2004·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Juergen MartinFriedhelm Beyersdorf
Jul 13, 2004·The American Journal of Cardiology·Douglas D ChristensenWilliam T Mahle
Nov 30, 2004·The American Journal of Cardiology·Jamshid AlaeddiniMandeep R Mehra
Dec 21, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Emma J BirksAsghar Khaghani
Dec 21, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Aparna KulkarniRalph Delius
Feb 5, 2005·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Sacha P SalzbergMarko I Turina

❮ Previous
Next ❯

Citations

May 11, 2011·Current Heart Failure Reports·Maya Guglin
Dec 23, 2010·Future Cardiology·Nathan Dwyer, David Kilpatrick
Aug 14, 2012·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James C FangRaymond L Benza
Jul 17, 2008·The Canadian Journal of Cardiology·Jonathan G Howlett
Feb 1, 2011·Revista española de cardiología·Luis AlmenarEnrique Pérez de la Sota
Jul 9, 2010·Journal of Cardiac Failure·Maya Guglin, Hammad Khan
Jun 7, 2011·International Journal of Cardiology·André P LourençoAdelino F Leite-Moreira
May 14, 2014·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Aditya K KazaMelanie D Everitt
Mar 24, 2010·Expert Opinion on Pharmacotherapy·Michael A Mathier, David Ishizawar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.